The Impact of Managed Care on the Substance Abuse Treatment Patterns and Outcomes of Medicaid Beneficiaries: Maryland's HealthChoice Program

Journal of Behavioral Health Services and Research

Volumn 30, Issue 1, 2003, Pages 41-62

  Ettner, Susan L ^a   Denmead, Gabrielle ^b   Dilonardo, Joan ^c   Cao, Hui ^d   Belanger, Albert J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Denmead and Associates Consulting   (United Kingdom)

^c Center for Substance Abuse Treatment   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; FEE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MANAGED CARE ORGANIZATION; MEDICAID; OUTPATIENT CARE; PROFIT; RESIDENTIAL CARE; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNITED STATES; ADDICTION; ADOLESCENT; AGED; COMPARATIVE STUDY; ECONOMICS; ETHNOLOGY; FEMALE; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; INSURANCE; MENTAL HEALTH SERVICE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; ELIGIBILITY DETERMINATION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE COVERAGE; MANAGED CARE PROGRAMS; MARYLAND; MEDICAID; MENTAL HEALTH SERVICES; MIDDLE AGED; PROGRAM EVALUATION; STATE HEALTH PLANS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 0037271004     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02287812     Document Type: Article

References (32)

1. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):9-19.
2. Weisner C, Schmidt L. Alcohol and drug problems among diverse health and social service populations. American Journal of Public Health. 1993;83(6):824-829.
3. Health Care Financing Administration. Medicare Managed Care Manual, 2002 http://cms.hhs.gov/manuals/116_mmc/mc86toc.asp. Last accessed May 15, 2002.
4. Deck DD, McFarland BH, Titus JM, et al. Access to substance abuse treatment services under the Oregon health plan. Journal of the American Medical Association. 2000;284(16):2093-2099.
5. Sturm R. Managed care risk contracts and substance abuse treatment. Inquiry. 2000;37(2):219-225.
6. Galanter M, Keller DS, Dermatis H, et al. The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine. Journal of Addictive Diseases. 2000;19(3):13-34.
7. Lemak CH, Alexander JA. Managed care and outpatient substance abuse treatment intensity. Journal of Behavioral Health Services & Research. 2001;28(1):12-29.
8. Stein B, Reardon E, Sturm R. Substance abuse service utilization under managed care: HMOs versus carve-out plans. Journal of Behavioral Health Services & Research. 1999;26(4):451-456.
9. Weisner C, McCarty D, Schmidt L. New directions in alcohol and drug treatment under managed care. American Journal of Managed Care. 1999;5:SP57-SP69.
10. Kelly JA. Substance abuse and mental health care: managed care, access, and clinical outcomes. American Association of Occupational Health Nurses Journal. 1997;45(9):439-445.
11. McNeese-Smith DK. Program directors' views of the effect of managed care on substance abuse programs in Los Angeles County. Psychiatric Service. 1998;49(10):1323-1329.
12. Manning W. The Logged Dependent Variable, Heteroskedasticity, and the Retransformation Problem. Journal of Health Economics. 1998; 17(3):247-382.
13. Oliver T. The collision of economics and politics in Medicaid managed care: reflections on the course of reform in Maryland. The Milbank Quarterly. 1998;76(1):59-101.
14. Ettner S, Johnson S. Do Adjusted Clinical Groups Provide an Incentive for HMOs To Avoid Substance Abusers? Evidence from the Maryland Health Choice Program for Medicaid Beneficiaries. Journal of Behavioral Services & Research.
15. Cook T, Campbell D. Quasi-Experimentation: Design and Analysis for Field Settings. New York: Rand-McNally; 1979.
16. D'Agostino R. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine. 1998;17:2265-2281.
17. Duan N. Smearing estimate: a nonparametric retransformation method. Journal of the American Statistical Association. 1983;78(383):605-610.
18. Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
19. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
20. Monahan SC, Finney JW. Explaining abstinence rates following treatment for alcohol abuse: a quantitative synthesis of patient, research design and treatment effects. Addiction. 1996;91(6):787-805.
21. Fiorentine R, Anglin MD. More is better: counseling participation and the effectiveness of outpatient drug treatment. Journal of Substance Abuse Treatment. 1996;13(4):341-348.
22. Fiorentine R, Anglin MD. Does increasing the opportunity for counseling increase the effectiveness of outpatient drug treatment? American Journal of Drug and Alcohol Abuse. 1997;23(3):369-382.
23. Kamara SG, Van Der Hyde VA. Outcomes of regular vs. extended alcohol/ drug outpatient treatment: I. Relapse, aftercare, and treatment re-entry. Medicine and Law. 1997;16(3):607-620.
24. Kamara SG, Van der Hyde VA. Outcomes of regular versus extended outpatient alcohol/drug treatment: II. Medical, psychiatric, legal and social problems. Medicine and Law. 1998;17(1):131-142.
25. Latimer WW, Newcomb M, Winters KC, et al. Adolescent substance abuse treatment outcome: the role of substance abuse problem severity, psychosocial, and treatment factors. Journal of Consulting and Clinical Psychology. 2000;68(4):684-696.
26. Moos RH, Finney JW, Ouimette PC, et al. A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes. Alcoholism: Clinical & Experimental Research. 1999;23(3):529-536.
27. Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric Services. 1999;50(12):1577-1583.
28. Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse. 2000;26(2):207-227.
29. Ouimette PC, Moos RH, Finney JW. Influence of outpatient treatment and 12-step group involvement on one-year substance abuse treatment outcomes. Journal of Studies on Alcohol. 1998;59(5):513-522.
30. Arroyo JA, Westerberg VS, Tonigan JS. Comparison of treatment utilization and outcome for Hispanics and non-Hispanic whites. Journal of Studies on Alcohol. 1998;59(3):286-291.
31. Rapp RC, Siegal HA, Li L, et al. Predicting postprimary treatment services and drug use outcome: a multivariate analysis. American Journal of Drug and Alcohol Abuse. 1998;24(4):603-615.
32. Campbell EM, Heal LW. Prediction of cost, rates, and staffing by provider and client characteristics. American Journal on Mental Retardation. 1995;100(1):17-35.